We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Antenatal Micronutrient Supplementation and Birth Weight

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00115271
Recruitment Status : Completed
First Posted : June 22, 2005
Last Update Posted : August 26, 2014
Information provided by (Responsible Party):

June 21, 2005
June 22, 2005
August 26, 2014
January 1999
May 2001   (Final data collection date for primary outcome measure)
  • Birth weight
  • 3-month infant mortality
Same as current
Complete list of historical versions of study NCT00115271 on ClinicalTrials.gov Archive Site
  • Infant morbidity
  • Maternal morbidity
  • Maternal nutritional status
  • Weight gain during pregnancy
  • Infant growth
Same as current
Not Provided
Not Provided
Antenatal Micronutrient Supplementation and Birth Weight
Maternal Micronutrient Supplementation to Reduce Low Birth Weight and Infant and Maternal Morbidity in Rural Nepal
The purpose of this study was to determine the effects of providing supplements containing alternative combinations of micronutrients during pregnancy on birth weight and other infant and maternal health and nutritional outcomes in a rural area of Nepal.

Maternal micronutrient deficiencies are common in the developing world and may influence intrauterine growth and fetal and neonatal health and survival. Currently, policies for antenatal supplementation beyond iron-folic acid are not in place in these settings. And yet, the efficacy of such supplementation strategies has not been well established. Specifically, it is not clear if multiple micronutrient combinations will enhance fetal growth and newborn health and survival compared to single or smaller combinations of micronutrients. Also, while birth weight may serve as a proxy measure of newborn health, infant morbidity and mortality needs direct examination.

Comparisons: Pregnant women received daily folic acid, folic acid plus iron, folic acid plus iron plus zinc, or a multiple micronutrient supplement containing 11 other nutrients all with vitamin A compared to a control group that received only vitamin A.

Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
  • Low Birth Weight
  • Infant Mortality
  • Pregnancy
  • Nutritional Status
Drug: Nutritional supplements
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
May 2001
May 2001   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Married women of reproductive age identified as a new pregnancy using a urine test

Exclusion Criteria:

  • Menopausal or sterilized woman or currently already pregnant or breastfeeding an infant <9 months of age
Sexes Eligible for Study: Female
15 Years to 45 Years   (Child, Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
Parul Christian, Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health
  • United States Agency for International Development (USAID)
  • Bill and Melinda Gates Foundation
  • Johns Hopkins University
Principal Investigator: Parul Christian, DrPH Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205
Johns Hopkins Bloomberg School of Public Health
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP